In studies on CTRP9 KO mice [21] and transgenic CTRP9 mice [9], results showed that pharmacologically elevated circulating CTRP9 exerted therapeutic effects on the obesity and obesity-associated insulin resistance. This evidence concerns the gene C1QTNF9 and obesity disorder.